Immunotherapy for Bladder Cancer
A physician-evaluated, immune-based approach for patients diagnosed with bladder cancer — including recurrent and advanced cases.
Bladder Cancer: Overview
Bladder cancer is commonly treated with surgery, intravesical therapy, chemotherapy, radiation, immunotherapy, or targeted therapy depending on the stage and risk profile. Many patients continue looking for additional options — especially when the disease is recurrent, advanced, or when standard treatments have not delivered the expected response.
NK Cell Immunotherapy offers a cellular approach designed to support the immune system's natural ability to identify and respond to abnormal cells.
"Bladder cancer can interact with the immune system in complex ways. Supporting NK cell activity may help address immune evasion that contributes to recurrence."
Giostar Medical Team
Why early action is Critical
Bladder cancer is one of the most common cancers in the United States — and can be highly recurrent.
new u.s. cases - 2025
85,000
new bladder cancer cases estimated in the U.S. in 2025. (American Cancer Society)
u.s. deaths - 2025
17,000+
deaths attributed to bladder cancer in the United States in 2025.
Advanced disease may affect
Urinary function
Pelvic comfort
Kidney function
Energy levels
Survival outcomes change significantly when disease spreads beyond the bladder. Timely evaluation is important to preserve available treatment pathways.
Why Consider Cellular Immunotherapy?
Natural Killer cells are part of the innate immune system and play an important role in tumor surveillance. For bladder cancer patients, this is especially relevant because bladder tumors can interact with the immune system in complex ways, and immune evasion may contribute to recurrence or progression.
Nk cell mechanism
How Natural Killer Cells Target Cancer
Tumor Cell
Cancer cells evade normal immune detection
NK Recognition
NK cells detect "missing self" signals on abnormal cells
Cytotoxic Release
NK cells deploy perforin and granzymes
Cell Elimination
Tumor cell undergoes targeted aproptosis
In the clinical program, NK cells are collected from the patient, expanded in a controlled laboratory setting, and reinfused under physician oversight — supporting the body's own immune targeting capacity.
NK Cell Therapy is designed to:
Support immune surveillance
Help the immune system recognize abnormal cells
Provide a systemic, whole-body immune approach
Complement a broader treatment strategy when medically appropriate
Are You a Candidate?
NK Cell Immunotherapy may be considered for patients who:
Have been diagnosed with bladder cancer
Are exploring complementary or alternative treatment options
Have advanced, recurrent, or metastatic disease
Have not responded as expected to conventional treatment
Want to support immune function during or after treatment
Are seeking a less invasive cellular therapy option
Every case is individually reviewed by our physician team to determine whether the patient is eligible.
Not all bladder cancer patients qualify for our program. Eligibility is determined individually through physician-led medical review. This page provides general educational context — not medical advice or a determination of suitability.
A Comprehensive Approach
Physician-led case review
In-house cellular laboratory processing
Nutritional support
International patient coordination
Clinical process
How the Process Works
Medical Evaluation
Your diagnosis, medical history, and treatment goals are reviewed by our physicians.
Immune Profiling & Blood Collection
A blood sample is collected to isolate immune cells and assess baseline function.
NK Cell Expansion
NK cells are activated and expanded in our specialized laboratory.
Controlled Reinfusion
Expanded NK cells are administered intravenously under clinical protocols.
Monitoring & Follow-Up
Progress is tracked through advanced laboratory testing and physician follow-up.
Next Step: Medical Review
If you or a family member has been diagnosed with breast cancer and is exploring additional options, the first step is to submit your case for physician review. Our team will assess your specific situation and respond with an eligibility determination.